Interestingly, these insulin-negative samples of the three ADi-100 1:4 responders correlated with terminal mBG levels in the hyperglycemic range (≥180 mg/dL), whereas those of the ADi-100 1:2 responders were below this threshold, demonstrating that only ADi-100 1:2, but not ADi-100 1:4, reversed hyperglycemia (Table 1). The gene discussed is INS; the disease is Hyperglycemia.